Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
January 10, 2008
Bristol-Myers Squibb Company and Avista Capital Partners, a private equity firm, announced recently that Avista had completed its acquisition of Bristol-Myers Squibb Medical Imaging, a business unit of Bristol-Myers Squibb. According to the manufacturer, Bristol- Myers Squibb Medical Imaging is a leading supplier of medical imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures.
Based in Billerica, Massachusetts, Bristol-Myers Squibb Medical Imaging provides medical imaging products primarily focused on cardiovascular diagnostic imaging to nuclear physicians, cardiologists, radiologists, internal medicine physicians, IDNs/GPOs and technologists/sonographers working in hospitals and outpatient clinics. The company supplies its products to hospitals, clinics and radiopharmacies in the U.S., as well as internationally in certain countries including Australia and Canada.
J.P. Morgan Securities Inc. served as financial advisor for Bristol-Myers Squibb and Cravath, Swaine & Moore LLP served as its legal counsel. Weil, Gotshal & Manges served as legal counsel for Avista Capital Partners.